This company listing is no longer active
HT60 Stock Overview
Learning 2 Sleep L2S AB (publ), a digital sleep clinic provides cognitive behavioral therapy treatment services for care of sleep problems through a digital platform.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Learning 2 Sleep L2S AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.0005 |
| 52 Week High | SEK 0.003 |
| 52 Week Low | SEK 0.0001 |
| Beta | 0 |
| 11 Month Change | -77.27% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 400.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| HT60 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | 2.3% | 4.5% |
| 1Y | n/a | 5.9% | 13.4% |
Return vs Industry: Insufficient data to determine how HT60 performed against the German Healthcare industry.
Return vs Market: Insufficient data to determine how HT60 performed against the German Market.
Price Volatility
| HT60 volatility | |
|---|---|
| HT60 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 3.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: HT60's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine HT60's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 12 | Lina Johansson | www.learningtosleep.se |
Learning 2 Sleep L2S AB (publ), a digital sleep clinic, focuses on the provision of cognitive behavioral therapy treatment services for care of sleep problems through a digital platform. The company was founded in 2010 and is based in Malmo, Sweden.
Learning 2 Sleep L2S AB (publ) Fundamentals Summary
| HT60 fundamental statistics | |
|---|---|
| Market cap | €771.90k |
| Earnings (TTM) | -€1.72m |
| Revenue (TTM) | €589.19k |
1.3x
P/S Ratio-0.4x
P/E RatioIs HT60 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HT60 income statement (TTM) | |
|---|---|
| Revenue | SEK 6.86m |
| Cost of Revenue | SEK 23.61m |
| Gross Profit | -SEK 16.75m |
| Other Expenses | SEK 3.30m |
| Earnings | -SEK 20.05m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.22 |
| Gross Margin | -244.31% |
| Net Profit Margin | -292.36% |
| Debt/Equity Ratio | 0% |
How did HT60 perform over the long term?
See historical performance and comparison